Investor directoryMedicxi
Medicxi specializes in biotechnology investments with a focus on innovative therapeutic solutions.
What they invest in
Geographies
EUUS
The facts
- Headquarters
- London, United Kingdom
- Founded
- 2016
Portfolio companies
More portfolio companies
Phathom Pharmaceuticals (NAS: PHAT)ProfoundBioCurevo VaccineD3 BioViceBioVaxcyte (NAS: PCVX)Rivus PharmaceuticalsAura Biosciences (NAS: AURA)Breakpoint TherapeuticsAldena TherpeuticsXenikosCheckmate PharmaceuticalsLeviceptAltesa BioSciencesFore BiotherapeuticsAlys PharmaceuticalsVaderis TherapeuticsDiasomeSynthorxCritical PressureVersanis BioApcinteXDivide & ConquerSydnexis
and 25 more
Recent rounds
Vaderis Therapeutics
USD 152 millionSeries BBiotech & PharmaTCGXleadLife SciencesleadGoldman SachsleadMedicxiOmega FundsPerceptive Advisors · +4 more in the source
Switzerlandprnewswire.com
Rounds Medicxi took part in, as reported by the linked articles. See who else is investing right now.
Questions founders ask
- Which stages does Medicxi invest in?
- Medicxi invests at Growth, Series A, Series B and Seed.
- Where is Medicxi based?
- Medicxi is headquartered in London, United Kingdom.
Search investors like this in Claude — no account, no sign-in. Open in Claude
Are you Medicxi? Tell us what to correct and we will update it — or ask us to remove the entry.